I often feel the same way, but I won't claim to be

I often feel the same way, but I won't claim to be an expert, just an opinion based on years of watching it happen.

I suppose if we looked at how Hirsch managed other companies we might learn the direction he'll take here.

I know the trials they're running are rather small and all being done in Israel, but the company would get a lot more exposure if they were in the clinical trials database as they initially did with the cream. Of course we would have been far better informed if they'd updated the file for the cream. Doing all these things take time, and I suspect that may be the reason it's not happening. I know that this is a bare bones operation, but it would seem to me that having an employee who could do these things might be wise, perhaps even part time.

I believe that better informed investors would lead to higher stock prices. While Hirsch's letters are positive, you're still left with all sorts of unanswered questions. I recognize that some questions can't or won't be answered by any company, but I'm speaking about questions that most companies would answer beyond any doubt like, are the people in the fibromyalgia trial suffering from the disease.

Gary